Related Party Transactions (Details Textual) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|---|
Jun. 09, 2015 |
Feb. 11, 2015 |
Dec. 09, 2013 |
Jun. 30, 2015 |
Jun. 30, 2014 |
Jun. 30, 2015 |
Jun. 30, 2014 |
Dec. 31, 2014 |
|
Related Party Transactions (Textual) | ||||||||
Underwritten offering common stock, Shares | 2,609,001 | 2,609,501 | ||||||
Stock issued during period value under subscription agreements | $ 7,742,451 | $ 7,748,451 | ||||||
Placement agent [Member] | ||||||||
Related Party Transactions (Textual) | ||||||||
Description of receivables of placement agent for services | Agreement entered in on December 9, 2013 included a cash fee equal to 10% of the gross proceeds raised, a non-accountable expense reimbursement equal to 2% of the gross proceeds raised and warrants to purchase shares of the Company's Common Stock. | |||||||
Description of warrants receivables by placement | Warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued or issuable. | |||||||
Monthly fee for financial advisory services | $ 25,000 | |||||||
Repayment of amount paid to placement agent | 25,000 | $ 25,000 | ||||||
Subscription Agreements [Member] | ||||||||
Related Party Transactions (Textual) | ||||||||
Amount paid to placement agent | $ 400,000 | |||||||
Underwritten offering common stock, Shares | 1,923,078 | |||||||
Stock issued during period value under subscription agreements | $ 5,000,000 | |||||||
Share price | $ 2.6 | |||||||
IPO [Member] | ||||||||
Related Party Transactions (Textual) | ||||||||
Amount paid to placement agent | $ 1,400,000 | |||||||
Underwritten offering common stock, Shares | 4,444,444 | |||||||
Underwriting discount | $ 20,000,000 | |||||||
Gross proceeds received in Offering | $ 18,500,000 | |||||||
MSKCC [Member] | ||||||||
Related Party Transactions (Textual) | ||||||||
Maintenance fees | $ 180 | $ 0 | $ 145,255 | $ 189,537 | ||||
Royalty description | Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire. | |||||||
MSKCC [Member] | Clinical Trial Agreement [Member] | ||||||||
Related Party Transactions (Textual) | ||||||||
Maintenance fees | $ 0 | $ 189,537 |